Search Results - "Widuchowska, Malgorzata"

Refine Results
  1. 1

    CHLD score, a new score based on traditional risk factor evaluation and long-term cardiovascular outcomes in patients with systemic sclerosis by Gieszczyk-Strózik, Klaudia, Wybraniec, Maciej T., Widuchowska, Małgorzata, Brzezińska-Wcisło, Ligia, Kotyla, Przemysław, Kucharz, Eugeniusz, Mizia-Stec, Katarzyna

    Published in Scientific reports (01-10-2021)
    “…The aim of the study was to assess the predictors of major adverse cardiovascular events (MACE) in patients with systemic sclerosis (SSc) without pulmonary…”
    Get full text
    Journal Article
  2. 2

    Femoral press-fit fixation in ACL reconstruction using bone-patellar tendon-bone autograft: results at 15 years follow-up by Widuchowski, Wojciech, Widuchowska, Malgorzata, Koczy, Bogdan, Dragan, Szymon, Czamara, Andrzej, Tomaszewski, Wieslaw, Widuchowski, Jerzy

    Published in BMC musculoskeletal disorders (27-06-2012)
    “…If anterior cruciate ligament (ACL) reconstruction is to be performed, decision regarding graft choice and its fixation remains one of the most controversial…”
    Get full text
    Journal Article
  3. 3

    High acute phase protein levels correlate with pulmonary and skin involvement in patients with diffuse systemic sclerosis by Lis-Święty, Anna, Widuchowska, Małgorzata, Brzezińska-Wcisło, Ligia, Kucharz, Eugeniusz

    Published in Journal of international medical research (01-04-2018)
    “…Objective This study was performed to evaluate the serum amyloid A (SAA) and C-reactive protein (CRP) levels in patients with diffuse systemic sclerosis (dSSc)…”
    Get full text
    Journal Article
  4. 4

    Calprotectin in rheumatic diseases: a review by Kopeć-Mędrek, Magdalena, Widuchowska, Małgorzata, Kucharz, Eugeniusz J

    Published in Reumatologia (2016)
    “…Calprotectin also known as MRP8/14 or S100A8/A9 is a heterodimeric complex of two S100 calcium-binding proteins: myeloid-related protein 8 (MRP-8 or S100A8)…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Hip resurfacing arthroplasty in treatment of avascular necrosis of the femoral head by Pyda, Michał, Koczy, Bogdan, Widuchowski, Wojciech, Widuchowska, Małgorzata, Stołtny, Tomasz, Mielnik, Michał, Hermanson, Jacek

    Published in Medical science monitor (25-01-2015)
    “…Hip resurfacing is a conservative type of total hip arthroplasty but its use is controversial, especially in patients with osteonecrosis. The aim of this study…”
    Get full text
    Journal Article
  7. 7

    Serum ghrelin in female patients with rheumatoid arthritis during treatment with infliximab by Magiera, Michal, Kopec-Medrek, Magdalena, Widuchowska, Małgorzata, Kotulska, Anna, Dziewit, Tomasz, Ziaja, Damian, Kucharz, Eugene J., Logiewa-Bazger, Beata, Mazur, Wlodzimierz

    Published in Rheumatology international (01-06-2013)
    “…Ghrelin is a gastric hormone that posses multiple functions, including induction of growth hormone release, regulation of proinflammatory cytokines and control…”
    Get full text
    Journal Article
  8. 8

    ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysis by Bütikofer, Lukas, Varisco, Pierre A, Distler, O, Kowal-Bielecka, O, Allanore, Y, Riemekasten, G, Villiger, P M, Adler, S

    Published in Arthritis research & therapy (24-03-2020)
    “…To investigate the effect of ACE inhibitors (ACEi) on the incidence of scleroderma renal crisis (SRC) when given prior to SRC in the prospectively collected…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database by Maurer, Britta, Graf, Nicole, Michel, Beat A, Müller-Ladner, Ulf, Czirják, László, Denton, Christopher P, Tyndall, Alan, Metzig, Carola, Lanius, Vivian, Khanna, Dinesh, Distler, Oliver

    Published in Annals of the rheumatic diseases (01-06-2015)
    “…To identify predictive parameters for the progression of skin fibrosis within 1 year in patients with diffuse cutaneous SSc (dcSSc). An observational study…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13

    Opinion of patients with ankylosing spondylitis on risk factors impairing their quality of life by Kucharz, Eugene J., Kotulska, Anna, Kopeć-Mędrek, Magdalena, Widuchowska, Małgorzata

    Published in Rheumatology international (01-11-2013)
    “…We studied 54 patients with ankylosing spondylitis with questionnaire in order to determine their view on threat to quality of their life related to the…”
    Get full text
    Journal Article
  14. 14

    Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis by Dobrota, Rucsandra, Maurer, Britta, Graf, Nicole, Jordan, Suzana, Mihai, Carina, Kowal-Bielecka, Otylia, Allanore, Yannick, Distler, Oliver

    Published in Annals of the rheumatic diseases (01-10-2016)
    “…Improvement of skin fibrosis is part of the natural course of diffuse cutaneous systemic sclerosis (dcSSc). Recognising those patients most likely to improve…”
    Get more information
    Journal Article
  15. 15

    Co-existence of Lichen Sclerosus and Localized Scleroderma in Female Monozygotic Twins by Lis-Święty, Anna, MD, PhD, Mierzwińska, Katarzyna, MD, Wodok-Wieczorek, Karolina, MD, Widuchowska, Małgorzata, MD, PhD, Brzezińska-Wcisło, Ligia, MD, PhD

    “…Abstract Background Etiology of lichen sclerosus (LiS) and localized scleroderma (LoS) is uncertain and probably multifactorial. Case We describe a case of…”
    Get full text
    Journal Article
  16. 16

    Subacute cutaneous lupus erythematosus in the course of rheumatoid arthritis: a relationship with TNF-α antagonists and rituximab therapy? by Lis- wi ty, Anna, Brzezi ska-Wcis o, Ligia, Widuchowska, Ma gorzata, Kucharz, Eugeniusz

    Published in Immunopharmacology and immunotoxicology (01-06-2013)
    “…Abstract Introduction: Drug-induced subacute cutaneous lupus erythematosus (DI-SCLE) is caused by different medicines, first of all: calcium channel blockers,…”
    Get full text
    Journal Article
  17. 17

    Plasma leptin and neuropeptide Y concentrations in patients with rheumatoid arthritis treated with infliximab, a TNF-α antagonist by Kopec-Medrek, Magdalena, Kotulska, Anna, Widuchowska, Malgorzata, Adamczak, Marcin, Więcek, Andrzej, Kucharz, Eugene J.

    Published in Rheumatology international (01-11-2012)
    “…TNF-α is one of the key proinflammatory cytokines in pathogenesis of rheumatoid arthritis (RA). TNF-α was also found to enhance synthesis of leptin. Leptin is…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Subacute cutaneous lupus erythematosus in the course of rheumatoid arthritis: a relationship with TNF-[alpha] antagonists and rituximab therapy? by Lis-Swiety, Anna, Brzeziriska-Wcislo, Ligia, Widuchowska, Malgorzata, Kucharz, Eugeniusz

    Published in Immunopharmacology and immunotoxicology (01-06-2013)
    “…Introduction: Drug-induced subacute cutaneous lupus erythematosus (DI-SCLE) is caused by different medicines, first of all: calcium channel blockers,…”
    Get full text
    Journal Article
  20. 20